Pfizer 2010 Annual Report Download - page 57

Download and view the complete annual report

Please find page 57 of the 2010 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

Consolidated Statements of Shareholders’ Equity
Pfizer Inc. and Subsidiary Companies
PFIZER INC. SHAREHOLDERS
NON-
CONTRO-
LLING
INTERESTS
TOTAL
SHARE-
HOLDERS’
EQUITY
PREFERRED
STOCK
COMMON
STOCK
ADD’L
PAID-IN
CAPITAL
EMPLOYEE
BENEFIT
TRUSTS TREASURY STOCK
RETAINED
EARNINGS
ACCUM.
OTHER
COMP.
(LOSS)/
INC.
SHARE-
HOLDERS’
EQUITY
(MILLIONS, EXCEPT
PREFERRED SHARES) SHARES
STATED
VALUE SHARES
PAR
VALUE SHARES
FAIR
VALUE SHARES COST
Balance, January 1, 2008 2,302 $ 93 8,850 $442 $69,913 (24) $(550) (2,089) $(56,847) $ 49,660 $ 2,299 $65,010 $ 114 $65,124
Comprehensive income:
Net income 8,104 8,104 23 8,127
Other comprehensive
loss, net of tax (6,868) (6,868) 35 (6,833)
Total comprehensive income 1,236 58 1,294
Cash dividends declared—
common stock (8,617) (8,617) (8,617)
preferred stock (5) (5) (5)
Stock option transactions 207 1 32 239 239
Purchases of common stock (26) (500) (500) (500)
Employee benefit trust
transactions—net (113) (1) 93 (20) (20)
Preferred stock conversions and
redemptions (498) (20) (7) 2 (25) (25)
Other 13 1 283 (2) (46) 238 12 250
Balance, December 31, 2008 1,804 73 8,863 443 70,283 (24) (425) (2,117) (57,391) 49,142 (4,569) 57,556 184 57,740
Comprehensive income:
Net income 8,635 8,635 9 8,644
Other comprehensive
income, net of tax 5,121 5,121 5 5,126
Total comprehensive income 13,756 14 13,770
Acquisition of Wyeth 1,319 35,733 (12,430) 23,303 330 23,633
Cash dividends declared—
common stock (4,916) (4,916) (4,916)
preferred stock (5) (5) (5)
Noncontrolling interests (5) (5)
Stock option transactions 130 9 139 139
Employee benefit trust
transactions—net (61) 7 111 50 50
Preferred stock conversions and
redemptions (293) (12) (1) 3 (10) (10)
Purchase of subsidiary shares from
noncontrolling interests (66) (66) (102) (168)
Other 6 212 (2) (28) (1) 23 207 11 218
Balance, December 31, 2009 1,511 61 8,869 443 70,497 (19) (333) (799) (21,632) 40,426 552 90,014 432 90,446
Comprehensive income:
Net income 8,257 8,257 32 8,289
Other comprehensive
loss, net of tax (3,992) (3,992) 4 (3,988)
Total comprehensive income 4,265 36 4,301
Cash dividends declared—
common stock (5,964) (5,964) (5,964)
preferred stock (3) (3) (3)
Noncontrolling interests (17) (17)
Stock option transactions 161 1 14 175 175
Purchases of common stock (61) (1,000) (1,000) (1,000)
Employee benefit trust
transactions—net (19) 16 292 273 273
Preferred stock conversions and
redemptions (232) (9) (1) 2 (8) (8)
Other 7 1 122 2 20 (4) (82) 61 1 62
Balance, December 31, 2010 1,279 $ 52 8,876 $444 $70,760 $ (7) (864) $(22,712) $ 42,716 $(3,440) $87,813 $ 452 $88,265
See Notes to Consolidated Financial Statements, which are an integral part of these statements.
2010 Financial Report 55